Cornelius J Clancy Selected Research

Candidemia

1/2019	Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative.
2/2018	Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences.
1/2018	Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.
1/2018	Diagnosing Invasive Candidiasis.
1/2018	Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.
2/2016	Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies.
1/2016	Diagnostic Methods for Detection of Blood-Borne Candidiasis.
12/2015	Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection.
9/2015	Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.
5/2013	Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cornelius J Clancy Research Topics

Disease

35	Infections 07/2023 - 11/2005
19	Candidiasis (Moniliasis) 04/2023 - 10/2003
14	Candidemia 01/2019 - 08/2005
12	Invasive Candidiasis 11/2021 - 05/2006
7	Bacteremia 12/2022 - 03/2015
7	Mycoses (Diseases, Fungus) 06/2022 - 01/2010
7	COVID-19 10/2021 - 09/2020
6	Communicable Diseases (Infectious Diseases) 01/2022 - 09/2015
4	Pneumonia (Pneumonitis) 11/2021 - 01/2016
4	Sepsis (Septicemia) 10/2021 - 09/2015
4	Invasive Pulmonary Aspergillosis 01/2015 - 06/2007
3	Urinary Tract Infections (Urinary Tract Infection) 10/2020 - 03/2017
2	Septic Shock (Toxic Shock Syndrome) 11/2023 - 12/2012
2	Coinfection 10/2021 - 09/2020
2	Invasive Fungal Infections 01/2021 - 01/2010
2	Neutropenia 01/2018 - 09/2010
2	Abdominal Abscess 10/2017 - 09/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 07/2011
2	Breakthrough Infections 12/2014 - 01/2014
2	Skin Neoplasms (Skin Cancer) 12/2011 - 11/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2011 - 11/2010
2	Neoplasms (Cancer) 11/2010 - 06/2010
1	Gram-Negative Bacterial Infections 12/2022
1	Mucormycosis 01/2022
1	Liver Diseases (Liver Disease) 12/2021
1	Rupture 04/2021
1	Empyema 04/2021
1	Clostridium Infections 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Bacteriuria 10/2020
1	Reinfection 01/2020
1	Intraabdominal Infections 08/2019
1	Respiratory Sounds (Crackle) 03/2017
1	Exanthema (Rash) 01/2017
1	Pseudomonas Infections 01/2017
1	Drug-Related Side Effects and Adverse Reactions 12/2016
1	Surgical Wound Infection 10/2016
1	Cholangitis 09/2016

Drug/Important Bio-Agent (IBA)

15	Carbapenems (Carbapenem Antibiotics)IBA 07/2023 - 03/2015
14	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2017
11	EchinocandinsIBA 11/2021 - 09/2012
8	polyglucosanIBA 12/2019 - 05/2012
8	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2005
7	Fluconazole (Zonal)FDA LinkGeneric 04/2023 - 08/2005
7	ceftazidime drug combination avibactamIBA 08/2019 - 12/2016
5	galactomannanIBA 01/2015 - 06/2007
5	Immunoglobulin G (IgG)IBA 05/2013 - 05/2006
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2013
4	AntigensIBA 10/2021 - 06/2003
4	MannansIBA 02/2018 - 05/2013
4	Caspofungin (Cancidas)FDA Link 12/2013 - 09/2012
3	Antifungal AgentsIBA 06/2022 - 09/2015
3	meropenem and vaborbactamIBA 01/2020 - 01/2019
3	Colistin (Coly-Mycin)FDA Link 08/2019 - 06/2012
3	Valganciclovir FDA Link 01/2014 - 09/2010
3	Voriconazole (Vfend)FDA LinkGeneric 12/2011 - 01/2010
2	AzolesIBA 11/2021 - 06/2010
2	VaccinesIBA 10/2021 - 01/2021
2	BNT162 VaccineIBA 10/2021 - 01/2021
2	Vancomycin FDA LinkGeneric 10/2021 - 01/2021
2	Anti-Infective Agents (Microbicides)IBA 01/2021 - 01/2021
2	PorinsIBA 01/2020 - 03/2015
2	tazobactam drug combination ceftolozaneIBA 01/2018 - 01/2017
2	posaconazole FDA Link 01/2016 - 06/2010
2	Doripenem FDA Link 03/2015 - 06/2012
2	Antiviral Agents (Antivirals)IBA 08/2014 - 01/2014
2	Anidulafungin FDA Link 12/2013 - 08/2009
2	EnzymesIBA 08/2013 - 05/2008
2	AntibodiesIBA 04/2009 - 11/2008
2	Immunoglobulin M (IgM)IBA 05/2008 - 05/2006
2	Virulence Factors (Pathogenicity Factors)IBA 08/2006 - 09/2005
1	Prednisone (Sone)FDA LinkGeneric 11/2021
1	Linezolid (Zyvox)FDA Link 10/2021
1	Daptomycin FDA Link 10/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2021
1	FidaxomicinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Polymyxin B (Aerosporin)FDA LinkGeneric 08/2019
1	Polymyxins (Polymyxin)IBA 08/2019
1	plazomicinIBA 08/2019
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2019
1	avibactamIBA 01/2019
1	isavuconazoleIBA 12/2018
1	Fosfomycin FDA Link 03/2017
1	Meropenem (Merrem)FDA LinkGeneric 01/2017
1	RNA (Ribonucleic Acid)IBA 09/2016
1	AminoglycosidesIBA 01/2016
1	SuspensionsIBA 01/2016

Therapy/Procedure

20	Therapeutics 11/2023 - 08/2005
6	Lung Transplantation 11/2021 - 01/2010
4	Drug Therapy (Chemotherapy) 01/2018 - 06/2010
3	Home Nursing (Nursing, Home) 10/2021 - 09/2020
1	Bedding and Linens (Linens) 01/2022
1	Transplantation 12/2021
1	Urinary Catheters 10/2020
1	Catheters 10/2020
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018
1	Duration of Therapy 01/2018
1	Liver Transplantation 10/2016
1	Aftercare (After-Treatment) 09/2016